366 related articles for article (PubMed ID: 26094172)
1. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.
Smith BD; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Shirvani SM
J Geriatr Oncol; 2015 Jul; 6(4):324-31. PubMed ID: 26094172
[TBL] [Abstract][Full Text] [Related]
2. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
[TBL] [Abstract][Full Text] [Related]
3. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.
Paul S; Lee PC; Mao J; Isaacs AJ; Sedrakyan A
BMJ; 2016 Jul; 354():i3570. PubMed ID: 27400862
[TBL] [Abstract][Full Text] [Related]
4. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ
Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093
[TBL] [Abstract][Full Text] [Related]
6. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
7. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
8. Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.
Louie AV; Rodrigues GB; Palma DA; Senan S
Oncologist; 2014 Aug; 19(8):880-5. PubMed ID: 24951606
[TBL] [Abstract][Full Text] [Related]
9. SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?
Chen H; Louie AV
Curr Treat Options Oncol; 2016 Jun; 17(6):27. PubMed ID: 27098533
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.
Shirvani SM; Jiang J; Chang JY; Welsh JW; Gomez DR; Swisher S; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1060-70. PubMed ID: 22975611
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
Kim D; Ferraris VA; Davenport D; Saha S
South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
[TBL] [Abstract][Full Text] [Related]
12. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
Mahmood S; Bilal H; Faivre-Finn C; Shah R
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
Chen H; Laba JM; Boldt RG; Goodman CD; Palma DA; Senan S; Louie AV
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):186-194. PubMed ID: 29619964
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
16. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
Trials; 2016 Apr; 17():191. PubMed ID: 27053091
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
[TBL] [Abstract][Full Text] [Related]
18. Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer.
Fernandez FG; Crabtree TD; Liu J; Meyers BF
Ann Thorac Surg; 2012 Aug; 94(2):354-60; discussion 360-1. PubMed ID: 22429673
[TBL] [Abstract][Full Text] [Related]
19. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
